3.12.21
7 min. Read

Blues’ verdict on PDTs: No. Pharma digital spin-offs.

Welcome back to E&O Fridays, a paying subscribers-only weekly newsletter focused on the world of digital pharma products and FDA-regulated digital health.

 E&O Fridays.

OK, here's what's happening this week in the world of pharma digital products and FDA-regulated digital health:

  • Cognito Therapeutics shared results from its Phase II study and plans to move onto its pivotal study for its prescription digital therapeutic for Alzheimer's. Here's more about the PhII. (Remember: This one is a Breakthrough device and since it runs on its own hardware, it's likely a lay-up for the new MCIT reimbursement pathway.)
  • Mahana Therapeutics received a CE mark for its IBS-focused, prescription digital therapeutic, Parallel.
  • Empatica also received a CE mark for its wearable device, Aura, which certifies that it can detect and alert wearers to respiratory infections (including

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
New state launches for Midi Health, HeyJane, Swing Care and more
12.21.23
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
12.15.23
8 min. Read
Teladoc customer wins. Pricing database updates
12.08.23
5 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
12.01.23
6 min. Read
UnitedHealth’s employee benefits. Omada signals IPO. Detailed Spring Health pricing.
11.21.23
9 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
11.16.23
8 min. Read
Lyra Health pricing. Spring Health signals IPO.
11.09.23
6 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
11.06.23
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
10.27.23
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
10.20.23
6 min. Read
  • First
  • Previous
  • 1 of 35
  • Next
  • Last